Publication | Closed Access
Santolinolide B [(2R,3S,4S)-4-hydroxy-2,5-dimethyl-3-vinyl-5-hexenoic acid lactone]. A new irregular monoterpene from Artemisia tridentata tridentata
27
Citations
0
References
1979
Year
Bioorganic ChemistryEngineeringBiochemistryDonut IconNatural SciencesArtemisia Tridentata TridentataAltmetric Attention ScoreSecondary MetaboliteOrganic ChemistrySocial Media PresencePhytochemicalPhytopharmacologyPhytochemistryPharmacologyNew Irregular MonoterpeneBioprospectingBiomolecular EngineeringNatural Product Synthesis
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTSantolinolide B [(2R,3S,4S)-4-hydroxy-2,5-dimethyl-3-vinyl-5-hexenoic acid lactone]. A new irregular monoterpene from Artemisia tridentata tridentataWilliam W. Epstein and Larry A. GaudiosoCite this: J. Org. Chem. 1979, 44, 18, 3113–3117Publication Date (Print):August 1, 1979Publication History Published online1 May 2002Published inissue 1 August 1979https://pubs.acs.org/doi/10.1021/jo01332a006https://doi.org/10.1021/jo01332a006research-articleACS PublicationsRequest reuse permissionsArticle Views100Altmetric-Citations25LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts